chelerythrine has been researched along with nitroglycerin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, S; Bolli, R; Dawn, B; Manchikalapudi, S; Qiu, Y; Shirk, G; Takano, H; Tang, XL | 1 |
| Duncker, L; Förstermann, U; Hartmann, M; Hink, U; Li, H; Matheis, E; Meinertz, T; Mollnau, H; Münzel, T; Oelze, M; Skatchkov, M; Warnholtz, A | 1 |
| Baharvand, B; Dehaj, ME; Kiani, AA; Namdari, M; Rasoulian, B; Shikhani, Y | 1 |
3 other study(ies) available for chelerythrine and nitroglycerin
| Article | Year |
|---|---|
Nitroglycerin induces late preconditioning against myocardial stunning via a PKC-dependent pathway.
Topics: Alkaloids; Animals; Benzophenanthridines; Cardiotonic Agents; Enzyme Inhibitors; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion; Myocardial Stunning; Myocardium; Nitroglycerin; Phenanthridines; Protein Kinase C; Rabbits; Systole; Time Factors | 1999 |
Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability.
Topics: Acetylcholine; Alkaloids; Animals; Arginine; Benzophenanthridines; Biological Availability; Calcimycin; Carbazoles; Cloning, Molecular; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Indoles; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroglycerin; Phenanthridines; Protein Kinase C; Rats; Rats, Wistar; RNA, Messenger; Superoxides; Time; Vasodilation | 2000 |
Delayed anti-arrhythmic effect of nitroglycerin in anesthetized rats: involvement of CGRP, PKC and mK ATP channels.
Topics: Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzophenanthridines; Calcitonin Gene-Related Peptide; Cardiotonic Agents; Coronary Circulation; Decanoic Acids; Disease Models, Animal; Hydroxy Acids; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Nitroglycerin; Potassium Channels; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Wistar; Vasodilator Agents | 2009 |